Masha Paule Nathalie Strømme
Direktor/Vorstandsmitglied bei EXACT THERAPEUTICS
Vermögen: 2 Mio $ am 31.05.2024
Profil
Masha Paule Nathalie Strømme is the founder of Fortuna Fix, Inc. She currently holds the position of Co-Chairman at PAACS Invest AS since 2015, Vice Chairman at EXACT Therapeutics AS since 2015, and Director at Hemispherian AS.
Previously, she served as Director at Aqua Bio Technology ASA from 2011 to 2012, Director at ArcticZymes Technologies ASA, Director at Navamedic ASA from 2008 to 2015, and Director at Pharmasum Therapeutics AS.
Dr. Strømme obtained her doctorate degree from the University of Oxford in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EXACT THERAPEUTICS AS
8,39% | 04.01.2023 | 2 691 509 ( 8,39% ) | 2 Mio $ | 31.05.2024 |
Aktive Positionen von Masha Paule Nathalie Strømme
| Unternehmen | Position | Beginn |
|---|---|---|
| EXACT THERAPEUTICS | Direktor/Vorstandsmitglied | 08.06.2022 |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Gründer | - |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Direktor/Vorstandsmitglied | - |
| PAACS Invest AS | Vorsitzender | 01.09.2015 |
Ehemalige bekannte Positionen von Masha Paule Nathalie Strømme
| Unternehmen | Position | Ende |
|---|---|---|
| NAVAMEDIC ASA | Direktor/Vorstandsmitglied | 30.10.2015 |
| AQUA BIO TECHNOLOGY ASA | Direktor/Vorstandsmitglied | 14.06.2012 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Direktor/Vorstandsmitglied | - |
| ARCTICZYMES TECHNOLOGIES ASA | Direktor/Vorstandsmitglied | - |
Ausbildung von Masha Paule Nathalie Strømme
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NAVAMEDIC ASA | Distribution Services |
| AQUA BIO TECHNOLOGY ASA | Process Industries |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| EXACT THERAPEUTICS | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
| PAACS Invest AS |
